Skip to main content
Erschienen in: Virchows Archiv 2/2006

01.02.2006 | Case Report

Nephroblastomatosis and loss of WT1 expression associated with trisomy 13

verfasst von: Frank Traub, Karin Sickmann, Mathewos Tessema, Ludwig Wilkens, Hans H. Kreipe, Kenji Kamino

Erschienen in: Virchows Archiv | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Trisomy 13 (Patau's syndrome) is a rare finding in newborns. The life span of babies affected by this chromosome abnormality is severely shortened, and multiple, partly severe malformations occur. In this study, we report on an unborn with trisomy 13 (artificially aborted on the 24th week) which showed, among other typical deformities, bilateral nephrogenic rests (nephroblastomatosis). Using molecular analysis, a loss of Wilms' tumor gene 1 (WT1) transcript and a biallelic expression of insulin growth factor 2 (IGF2) could be revealed. To our knowledge, this is the first reported case of trisomy 13 which showed this type of anomaly and gene expression findings.
Literatur
1.
Zurück zum Zitat Charles AK, Brown KW, Berry PJ (1998) Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development. Am J Pathol 153(3):991–1000PubMed Charles AK, Brown KW, Berry PJ (1998) Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development. Am J Pathol 153(3):991–1000PubMed
2.
Zurück zum Zitat Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III (1992) Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257(5070):674–678PubMedCrossRef Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III (1992) Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257(5070):674–678PubMedCrossRef
3.
Zurück zum Zitat Hennigar RA, O'Shea PA, Grattan-Smith JD (2001) Clinicopathologic features of nephrogenic rests and nephroblastomatosis. Adv Anat Pathol 8(5):276–289CrossRefPubMed Hennigar RA, O'Shea PA, Grattan-Smith JD (2001) Clinicopathologic features of nephrogenic rests and nephroblastomatosis. Adv Anat Pathol 8(5):276–289CrossRefPubMed
4.
Zurück zum Zitat Hu JF, Vu TH, Hoffman AR (1997) Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19. J Biol Chem 272(33):20715–20720CrossRefPubMed Hu JF, Vu TH, Hoffman AR (1997) Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19. J Biol Chem 272(33):20715–20720CrossRefPubMed
5.
Zurück zum Zitat Jones KL (1997) Trisomy 13 syndrome. In: Jones KJ (ed) Smith's recognizable patterns of human malformation, 5th edn. Saunders, Philadelphia, pp 18–19 Jones KL (1997) Trisomy 13 syndrome. In: Jones KJ (ed) Smith's recognizable patterns of human malformation, 5th edn. Saunders, Philadelphia, pp 18–19
6.
Zurück zum Zitat Keshgegian AA, Chatten J (1979) Nodular renal blastema in trisomy 13. Arch Pathol Lab Med 103:73–75PubMed Keshgegian AA, Chatten J (1979) Nodular renal blastema in trisomy 13. Arch Pathol Lab Med 103:73–75PubMed
7.
Zurück zum Zitat Lehmann U, Glockner S, Kleeberger W, von Wasielewski HF, Kreipe H (2000) Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am J Pathol 156(6):1855–1864PubMed Lehmann U, Glockner S, Kleeberger W, von Wasielewski HF, Kreipe H (2000) Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am J Pathol 156(6):1855–1864PubMed
8.
Zurück zum Zitat Miller RW, Fraument JF Jr, Manning MD (1964) Association of Wilms's tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 270:922–927PubMedCrossRef Miller RW, Fraument JF Jr, Manning MD (1964) Association of Wilms's tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 270:922–927PubMedCrossRef
9.
Zurück zum Zitat Patau K, Smith DW, Therman E, Inhorn SL, Wagner HP (1960) Multiple congenital anomaly caused by an extra autosome. Lancet 9:790–793CrossRef Patau K, Smith DW, Therman E, Inhorn SL, Wagner HP (1960) Multiple congenital anomaly caused by an extra autosome. Lancet 9:790–793CrossRef
10.
Zurück zum Zitat Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317(6034):258–260CrossRefPubMed Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317(6034):258–260CrossRefPubMed
11.
Zurück zum Zitat Schumacher V, Schuhen S, Sonner S, Weirich A, Leuschner I, Harms D, Licht J, Roberts S, Royer-Pokora B (2003) Two molecular subgroups of Wilms' tumors with or without WT1 mutations. Clin Cancer Res 9(6):2005–2014PubMed Schumacher V, Schuhen S, Sonner S, Weirich A, Leuschner I, Harms D, Licht J, Roberts S, Royer-Pokora B (2003) Two molecular subgroups of Wilms' tumors with or without WT1 mutations. Clin Cancer Res 9(6):2005–2014PubMed
12.
Zurück zum Zitat Strong LC (2003) The two-hit model for Wilms' tumor: where are we 30 years later? Genes Chromosomes Cancer 38(4):294–299CrossRefPubMed Strong LC (2003) The two-hit model for Wilms' tumor: where are we 30 years later? Genes Chromosomes Cancer 38(4):294–299CrossRefPubMed
13.
Zurück zum Zitat Sweeney H, Pelegano J (2000) Wilms tumor in a child with trisomy 13. J Pediatr Hematol Oncol 22(2):171–172CrossRefPubMed Sweeney H, Pelegano J (2000) Wilms tumor in a child with trisomy 13. J Pediatr Hematol Oncol 22(2):171–172CrossRefPubMed
14.
Zurück zum Zitat Tessema M, Langer F, Bock O, Seltsam A, Hasemeier B, Kreipe H, Lehmann U (2005) Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern. Int J Oncol 26(2):499–507PubMed Tessema M, Langer F, Bock O, Seltsam A, Hasemeier B, Kreipe H, Lehmann U (2005) Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern. Int J Oncol 26(2):499–507PubMed
15.
Zurück zum Zitat Weksberg R, Shen DR, Fei YL, Song QL, Squire J (1993) Disruption of insulin-like growth factor 2 imprinting in Beckwith–Wiedemann syndrome. Nat Genet 5(2):143–150CrossRefPubMed Weksberg R, Shen DR, Fei YL, Song QL, Squire J (1993) Disruption of insulin-like growth factor 2 imprinting in Beckwith–Wiedemann syndrome. Nat Genet 5(2):143–150CrossRefPubMed
16.
Zurück zum Zitat Wilkens L, Gerr H, Gadzicki D, Kreipe H, Schlegelberger B (2005) Standardized fluorescence in situ hybridisation in cytological and histological specimens. Virchows Archiv (in press) Wilkens L, Gerr H, Gadzicki D, Kreipe H, Schlegelberger B (2005) Standardized fluorescence in situ hybridisation in cytological and histological specimens. Virchows Archiv (in press)
Metadaten
Titel
Nephroblastomatosis and loss of WT1 expression associated with trisomy 13
verfasst von
Frank Traub
Karin Sickmann
Mathewos Tessema
Ludwig Wilkens
Hans H. Kreipe
Kenji Kamino
Publikationsdatum
01.02.2006
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 2/2006
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-005-0067-3

Weitere Artikel der Ausgabe 2/2006

Virchows Archiv 2/2006 Zur Ausgabe

Neu im Fachgebiet Pathologie